Pretzel Therapeutics Stock

Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.

Sign up today and learn more about Pretzel Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Pretzel Therapeutics Stock

Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinating features that make it unlike any other organelle in the body.

Funding History

September 2022$72.5M


Board of Directors

Robert Tansley

Board of Directors

Jay Parrish

Board of Directors

Alaa Halawa

Board of Directors

Per Samuelsson

Board Observer

Paolo Di Giorgio

Board Observer

Reetika Bhardwaj

Board of Directors

Kristina Burow


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: